Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Health economics of asthma and rhinitis. II. Assessing the value of interventions
Autore:
Sullivan, SD; Weiss, KB;
Indirizzi:
Rush Presbyterian St Lukes Med Ctr, Rush Primary Care Inst, Ctr Hlth Serv Res, Chicago, IL 60612 USA Rush Presbyterian St Lukes Med Ctr Chicago IL USA 60612 ago, IL 60612 USA Univ Washington, Sch Pharm, Dept Pharm Serv, Seattle, WA 98195 USA Univ Washington Seattle WA USA 98195 pt Pharm Serv, Seattle, WA 98195 USA Univ Washington, Sch Pharm, Dept Hlth Serv, Seattle, WA 98195 USA Univ Washington Seattle WA USA 98195 ept Hlth Serv, Seattle, WA 98195 USA
Titolo Testata:
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
fascicolo: 2, volume: 107, anno: 2001,
pagine: 203 - 210
SICI:
0091-6749(200102)107:2<203:HEOAAR>2.0.ZU;2-C
Fonte:
ISI
Lingua:
ENG
Soggetto:
COST-EFFECTIVENESS ANALYSIS; BRONCHODILATOR DELIVERY METHODS; METERED-DOSE INHALER; OBSTRUCTIVE PULMONARY-DISEASE; SEASONAL ALLERGIC RHINITIS; FLUTICASONE PROPIONATE; SELF-MANAGEMENT; HOSPITALIZED-PATIENTS; STRUCTURED TREATMENT; BRONCHIAL-ASTHMA;
Keywords:
asthma; allergic rhinitis; economics; cost-effectiveness analysis; costs;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
99
Recensione:
Indirizzi per estratti:
Indirizzo: Weiss, KB Rush Presbyterian St Lukes Med Ctr, Rush Primary Care Inst, Ctr Hlth Serv Res, 1653 W Congress Pkwy, Chicago, IL 60612 USA Rush Presbyterian St Lukes Med Ctr 1653 W Congress Pkwy Chicago IL USA 60612
Citazione:
S.D. Sullivan e K.B. Weiss, "Health economics of asthma and rhinitis. II. Assessing the value of interventions", J ALLERG CL, 107(2), 2001, pp. 203-210

Abstract

Health care providers and payers are being asked to weigh data on the economic impact of new interventions along with clinical evidence when making decisions about the care of patients, The notion of incorporating formal health economic assessments into clinical and resource decisions is a difficult concept for many in the health fare sector. However, it is the reality intoday's environment. To effectively participate in these ongoing discussions, clinicians and other decision makers must be able to understand and critically assess the evidence on economic impact of medical interventions. This second of 2 articles describes the elements of comparative economic evaluations, reviewing the published literature on asthma and rhinitis in an attempt to critically appraise the studies from the perspective of one who might use data for decision making. Unfortunately, the quality of the economic evidence in these two disease states is not extensive, Until better economic analyses are conducted and made available, the allocation of resources for asthma and allergic rhinitis will continue to primarily rely on expert opinion rather than evidence-based literature.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 03:57:01